X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3738) 3738
Book Review (394) 394
Publication (152) 152
Conference Proceeding (86) 86
Book Chapter (13) 13
Newspaper Article (10) 10
Magazine Article (5) 5
Dissertation (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clear cell-type renal cell carcinoma (2932) 2932
index medicus (2566) 2566
humans (1853) 1853
cancer (1608) 1608
tumors (1307) 1307
oncology (1303) 1303
metastasis (1059) 1059
female (1016) 1016
male (1005) 1005
kidney cancer (961) 961
metastases (918) 918
patients (857) 857
carcinoma, renal cell (832) 832
kidney transplantation (805) 805
middle aged (805) 805
renal cell carcinoma (786) 786
kidney neoplasms - pathology (777) 777
gene expression (729) 729
carcinoma, renal cell - pathology (707) 707
apoptosis (680) 680
aged (673) 673
proteins (653) 653
kidneys (651) 651
multidisciplinary sciences (575) 575
expression (572) 572
prognosis (564) 564
adult (563) 563
medicine (553) 553
survival (553) 553
pathology (538) 538
medical prognosis (536) 536
analysis (507) 507
research article (504) 504
kinases (484) 484
science (476) 476
carcinoma, renal cell - genetics (475) 475
research (458) 458
kidney neoplasms - genetics (432) 432
genetic aspects (430) 430
immunohistochemistry (422) 422
animals (413) 413
care and treatment (387) 387
biomarkers (386) 386
cell proliferation (378) 378
cell biology (376) 376
studies (369) 369
surgery (355) 355
cancer therapies (354) 354
nephrectomy (341) 341
medical research (340) 340
mutation (338) 338
development and progression (337) 337
kidney neoplasms - metabolism (332) 332
diagnosis (327) 327
urology (322) 322
carcinoma, renal cell - metabolism (318) 318
cell line, tumor (318) 318
carcinoma (313) 313
health aspects (312) 312
rodents (312) 312
signal transduction (311) 311
cell survival (303) 303
genes (302) 302
medicine & public health (301) 301
aged, 80 and over (296) 296
medicine, research & experimental (285) 285
urology & nephrology (285) 285
mice (280) 280
clear cell renal cell carcinoma (274) 274
therapy (269) 269
cell lines (262) 262
biology (260) 260
vascular endothelial growth factor (257) 257
kidney diseases (256) 256
cell cycle (254) 254
cell growth (249) 249
risk factors (248) 248
genomes (246) 246
carcinoma, renal cell - drug therapy (245) 245
angiogenesis (239) 239
kidney (238) 238
urologic and male genital diseases (238) 238
cell migration (237) 237
epithelial cells (236) 236
clinical trials (234) 234
gene expression regulation, neoplastic (232) 232
activation (230) 230
hypoxia (230) 230
immunotherapy (228) 228
inflammation (226) 226
kidney neoplasms - drug therapy (226) 226
inhibition (223) 223
biochemistry & molecular biology (215) 215
breast cancer (215) 215
renal function (214) 214
nephrology (213) 213
retrospective studies (211) 211
syngeneic grafts (211) 211
article (210) 210
chemotherapy (210) 210
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3698) 3698
German (23) 23
Chinese (14) 14
Japanese (9) 9
Spanish (8) 8
French (6) 6
Russian (6) 6
Polish (3) 3
Hungarian (1) 1
Korean (1) 1
Latvian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2017, Volume 87, pp. 147 - 163
Papillary renal-cell carcinoma type 1 (PRCC1) is associated with gene alterations. Our phase II trial prospectively assessed the efficacy and safety of... 
Crizotinib | Advanced papillary renal cell carcinoma type 1 (PRCC1) | MET tyrosine kinase inhibitor | MET mutations or amplification | ONCOLOGY | C-MET | SUNITINIB | PHASE-II | CLASSIFICATION | INHIBITOR | PROTOONCOGENE | TUMORS | Kidney Neoplasms - genetics | Pyrazoles - therapeutic use | Prospective Studies | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Pyridines - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Carcinoma, Renal Cell - enzymology | Female | Biomarkers, Tumor - antagonists & inhibitors | Carcinoma, Renal Cell - drug therapy | Pyrazoles - adverse effects | Pyridines - therapeutic use | Genetic Predisposition to Disease | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Europe | Kaplan-Meier Estimate | Treatment Outcome | Proto-Oncogene Proteins c-met - genetics | Disease-Free Survival | Phenotype | Gene Amplification | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - enzymology | Kidney Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Mutation | Kidney Neoplasms - drug therapy | Tyrosine | Genetic research | Genetic aspects | Carcinoma | Gene mutations | Cancer | Exons | Metastasis | Metastases | Gene sequencing | Confidence intervals | Alterations | Safety engineering | MET protein | Safety | Edema | Cell survival | Diarrhea | Fatigue | Nausea | Fatigue failure | Disease control | Patients | Survival | Amplification | Gene amplification | Experimental design | Kidney cancer | Solid tumors | Clear cell-type renal cell carcinoma | Tumors | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
by Linehan, W. Marston and Spellman, Paul T and Ricketts, Christopher J and Creighton, Chad J and Fei, Suzanne S and Davis, Caleb and Wheeler, David A and Murray, Bradley A and Schmidt, Laura and Vocke, Cathy D and Peto, Myron and Al Mamun, Abu Amar M and Shinbrot, Eve and Sethi, Anurag and Brooks, Samira and Rathmell, W. Kimryn and Brooks, Angela N and Hoadley, Katherine A and Robertson, A. Gordon and Brooks, Denise and Bowlby, Reanne and Sadeghi, Sara and Shen, Hui and Weisenberger, Daniel J and Bootwalla, Moiz and Baylin, Stephen B and Laird, Peter W and Cherniack, Andrew D and Saksena, Gordon and Haake, Scott and Li, Jun and Liang, Han and Lu, Yiling and Mills, Gordon B and Akbani, Rehan and Leiserson, Mark D.M and Raphael, Benjamin J and Anur, Pavana and Bottaro, Donald and Albiges, Laurence and Barnabas, Nandita and Choueiri, Toni K and Czerniak, Bogdan and Godwin, Andrew K and Hakimi, A. Ari and Ho, Thai H and Hsieh, James and Ittmann, Michael and Kim, William Y and Krishnan, Bhavani and Merino, Maria J and Shaw, Kenna R. Mills and Reuter, Victor E and Reznik, Ed and Shelley, Carl S and Shuch, Brian and Signoretti, Sabina and Srinivasan, Ramaprasad and Tamboli, Pheroze and Thomas, George and Tickoo, Satish and Burnett, Kenneth and Crain, Daniel and Gardner, Johanna and Lau, Kevin and Mallery, David and Morris, Scott and Paulauskis, Joseph D and Penny, Robert J and Shelton, Candace and Shelton, W. Troy and Sherman, Mark and Thompson, Eric and Yena, Peggy and Avedon, Melissa T and Bowen, Jay and Gastier-Foster, Julie M and Gerken, Mark and Leraas, Kristen M and Lichtenberg, Tara M and Ramirez, Nilsa C and Santos, Tracie and Wise, Lisa and Zmuda, Erik and Demchok, John A and Felau, Ina and Hutter, Carolyn M and Sheth, Margi and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Zhining and Yang, Liming and Zenklusen, Jean C and Zhang, Jiashan and Ayala, Brenda and Baboud, Julien and Chudamani, Sudha and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 2, pp. 135 - 145
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 722 - 731
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 23, pp. 2246 - 2254
Journal Article